Emicizumab-kxwh Subcutaneous and Indacaterol and glycopyrrolate Inhalation
Determining the interaction of Emicizumab-kxwh Subcutaneous and Indacaterol and glycopyrrolate Inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Indacaterol inhalation
- Emicizumab-kxwh Subcutaneous-Indacaterol Maleate
- Emicizumab-kxwh Subcutaneous-Indapamide
- Emicizumab-kxwh Subcutaneous-Inderal
- Emicizumab-kxwh Subcutaneous-Inderal Intravenous
- Emicizumab-kxwh Subcutaneous-Inderal LA
- Indacaterol and glycopyrrolate Inhalation-Emla
- Indacaterol and glycopyrrolate Inhalation-Emla Topical
- Indacaterol and glycopyrrolate Inhalation-Emo-Cort Scalp Solution Topical application
- Indacaterol and glycopyrrolate Inhalation-Emo-Cort Topical application
- Indacaterol and glycopyrrolate Inhalation-Emoquette
- Indacaterol and glycopyrrolate Inhalation-Empagliflozin